BMC Neurol

1. AHMED AM, Mistry N, Gehad AS, Hassan AM, et al
   Inflammatory CADASIL: the cross-link between CADASIL and multiple sclerosis: a report of two cases and systematic review of the literature.
   BMC Neurol. 2026;26:373.
   

   >> Share

   
   

   
   Brain

2. TUR C, Susin-Calle S, Otero-Romero S, Carvajal R, et al
   Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
   Brain. 2026 Jun 10:awag047. doi: 10.1093.
   

   >> Share

   
   
3. ARNABOLDI PM, Becker J, Nath A, Coyle PK, et al
   Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.
   Brain. 2026 May 18:awag016. doi: 10.1093.
   

   >> Share

   
   

   
   J Neurol

4. GUGER M, Enzinger C, Heschl B, Di Pauli F, et al
   The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.
   J Neurol. 2026;273:392.
   

   >> Share

   
   
5. FOTTINGER F, Krajnc N, Berek K, Nolte JP, et al
   Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.
   J Neurol. 2026;273:382.
   

   >> Share

   
   
6. ESPOSITO F, Misra K, Doyle F, Clarelli F, et al
   Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.
   J Neurol. 2026;273:374.
   

   >> Share

   
   
7. REUTER E, Luerweg J, Katsimpoura M, Haselon J, et al
   Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.
   J Neurol. 2026;273:372.
   

   >> Share

   
   
8. HOF SN, Keytsman E, Fuchs TAN, Wessels MHJ, et al
   What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
   J Neurol. 2026;273:355.
   

   >> Share

   
   

   
   Mult Scler

9. CHEN H, Cortese M, Flores-Torres MH, Chen X, et al
   Comorbidities and lifestyle changes as predictors of the multiple sclerosis prodrome: A prospective cohort study.
   Mult Scler. 2026 Jun 10:13524585261454827. doi: 10.1177/13524585261454827.
   

   >> Share

   
   
10. HAMEDANI M, Lombardi G, Boffa G, Pistarini C, et al
    Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.
    Mult Scler. 2026 Jun 9:13524585261450820. doi: 10.1177/13524585261450820.
    

    >> Share

    
    
11. MCCURDY S, Sheng E, Jalaleddini K, Datta G, et al
    Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.
    Mult Scler. 2026;32:711-721.
    

    >> Share

    
    
12. TALLANTYRE EC, Apap Mangion S, Teunissen CE
    A framework for blood biomarker discovery in MS.
    Mult Scler. 2026;32:661-669.
    

    >> Share

    
    

    
    Neurology

13. GUINEBRETIERE O, Yang F, Wei D, Calonge Q, et al
    Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).
    Neurology. 2026;107:e218072.
    

    >> Share

    
    

    
    PLoS One

14. GIOVANNETTI AM, Giordano A, Donarelli E, Di Domenico G, et al
    Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development.
    PLoS One. 2026;21:e0349034.
    

    >> Share

    
    
15. MARIKI A, Kohlmeier KA, Mousavi SM, Keyhani A, et al
    Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone -induced multiple sclerosis model.
    PLoS One. 2026;21:e0349675.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share